IVZ

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Invesco NYSE: IVZ reported record second-quarter net long-term inflows and higher profitability as demand for ETFs, fixed income, separately managed accounts and private-market strategies helped push assets under management to $2.5 trillion.

Harmony Biosciences, Invesco, GM, HPE and Quanex made the screen of low price-to-book stocks that also met multiple value metrics.

IVZ's Q2 earnings beat estimates as higher revenues, record inflows and a 23.4% AUM jump outweigh rising expenses.

While the top- and bottom-line numbers for Invesco (IVZ) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Invesco (IVZ) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.36 per share a year ago.

Invesco Announces Second Quarter Diluted EPS of $0.76; Adjusted Diluted EPS (1) of $0.71 ATLANTA, July 28, 2026 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ) today reported financial results for the three months ended June 30, 2026.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

IVZ's Q2 results may benefit from a 14.4% sequential rise in AUM, boosting fee revenues, even as performance fees are expected to normalize.

Invesco (IVZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.